eFFECTOR Therapeutics (EFTR)
OTHER OTC:EFTR

eFFECTOR Therapeutics (EFTR) Financial Statements

261 Followers

eFFECTOR Therapeutics Financial Overview

eFFECTOR Therapeutics's market cap is currently ―. The company's EPS TTM is $-13.315; its P/E ratio is >-0.01; eFFECTOR Therapeutics is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-2.02. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 27.00M---$ 675.00K
Gross Profit$ 27.00M---$ 675.00K
EBIT$ -8.09M$ -7.55M$ -7.64M$ -9.55M$ -8.77M
EBITDA$ -8.06M$ -7.53M-$ -9.58M$ -61.76M
Net Income Common Stockholders$ -8.83M$ -8.30M$ -8.36M$ -10.01M$ -9.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.38M$ 17.78M$ 25.02M$ 19.01M$ 26.31M
Total Assets$ 27.13M$ 20.16M$ 26.89M$ 21.71M$ 29.08M
Total Debt$ 232.00K$ 77.00K$ 94.00K$ 109.00K$ 120.00K
Net Debt$ -25.15M$ -17.70M$ -24.93M$ -18.90M$ -26.19M
Total Liabilities$ 26.30M$ 24.13M$ 24.31M$ 26.74M$ 25.18M
Stockholders Equity$ 827.00K$ -3.97M$ 2.58M$ -4.81M$ 3.94M
Cash Flow-
Free Cash Flow$ -7.28M$ -7.80M-$ -7.64M$ -6.78M
Operating Cash Flow$ -7.28M$ -7.75M$ -8.59M$ -7.64M$ -6.78M
Investing Cash Flow$ -6.32M$ -1.92M$ -1.57M$ 9.03M$ 3.62M
Financing Cash Flow$ 14.23M$ 342.00K$ 14.57M$ 212.00K$ -37.00K
Currency in USD

eFFECTOR Therapeutics Earnings and Revenue History

eFFECTOR Therapeutics Debt to Assets

eFFECTOR Therapeutics Cash Flow

eFFECTOR Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis